Alanazi M, Alshehri K, Alerwy F, Alrasheed T, Lahza H, Aref Albezrah N
BMC Endocr Disord. 2025; 25(1):56.
PMID: 40016702
PMC: 11869561.
DOI: 10.1186/s12902-025-01884-6.
Abdalla M
Ther Adv Endocrinol Metab. 2024; 15:20420188231222371.
PMID: 38250316
PMC: 10798122.
DOI: 10.1177/20420188231222371.
Chong H, Son J, Chae C, Jae C
Ann Occup Environ Med. 2023; 35:e40.
PMID: 38029272
PMC: 10654537.
DOI: 10.35371/aoem.2023.35.e40.
Mkhize B, Mosili P, Ngubane P, Khathi A
Adipocyte. 2023; 12(1):2249763.
PMID: 37606270
PMC: 10472858.
DOI: 10.1080/21623945.2023.2249763.
Batista J, Faria A, Ribeiro T, Simoes E Silva A
Life (Basel). 2023; 13(7).
PMID: 37511973
PMC: 10381689.
DOI: 10.3390/life13071598.
Tripeptide IRW Improves AMPK/eNOS Signaling Pathway via Activating ACE2 in the Aorta of High-Fat-Diet-Fed C57BL/6 Mice.
Ashkar F, Bhullar K, Jiang X, Wu J
Biology (Basel). 2023; 12(4).
PMID: 37106756
PMC: 10135585.
DOI: 10.3390/biology12040556.
Insulin resistance and cardiovascular disease.
Kosmas C, Bousvarou M, Kostara C, Papakonstantinou E, Salamou E, Guzman E
J Int Med Res. 2023; 51(3):3000605231164548.
PMID: 36994866
PMC: 10069006.
DOI: 10.1177/03000605231164548.
Pathophysiology and genetics of salt-sensitive hypertension.
Maaliki D, Itani M, Itani H
Front Physiol. 2022; 13:1001434.
PMID: 36176775
PMC: 9513236.
DOI: 10.3389/fphys.2022.1001434.
Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women.
Bielecka-Dabrowa A, Gryglewska K, Sakowicz A, Rybak M, Janikowski K, Banach M
J Cardiovasc Dev Dis. 2022; 9(8).
PMID: 36005402
PMC: 9409395.
DOI: 10.3390/jcdd9080238.
Codon-optimized FAM132b gene therapy prevents dietary obesity by blockading adrenergic response and insulin action.
Qi Z, Xia J, Xue X, Liu W, Huang Z, Zhang X
Int J Obes (Lond). 2022; 46(11):1970-1982.
PMID: 35922561
DOI: 10.1038/s41366-022-01189-x.
Sex Difference in the Associations among Obesity-Related Indices with Incident Hypertension in a Large Taiwanese Population Follow-Up Study.
Lee W, Wu P, Huang J, Tsai Y, Chiu Y, Chen S
J Pers Med. 2022; 12(6).
PMID: 35743756
PMC: 9225143.
DOI: 10.3390/jpm12060972.
Obesogenic and Ketogenic Diets Distinctly Regulate the SARS-CoV-2 Entry Proteins ACE2 and TMPRSS2 and the Renin-Angiotensin System in Rat Lung and Heart Tissues.
Da Eira D, Jani S, Ceddia R
Nutrients. 2021; 13(10).
PMID: 34684358
PMC: 8541329.
DOI: 10.3390/nu13103357.
Diet-induced prediabetes: Effects on the activity of the renin-angiotensin-aldosterone system in selected organs.
Mkhize B, Mosili P, Ngubane P, Sibiya N, Khathi A
J Diabetes Investig. 2021; 13(5):768-780.
PMID: 34619025
PMC: 9077724.
DOI: 10.1111/jdi.13690.
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19.
Ekholm M, Kahan T
Front Pharmacol. 2021; 12:640185.
PMID: 34220496
PMC: 8245685.
DOI: 10.3389/fphar.2021.640185.
Impact of adipose tissue in chronic kidney disease development (Review).
Miricescu D, Balan D, Tulin A, Stiru O, Vacaroiu I, Mihai D
Exp Ther Med. 2021; 21(5):539.
PMID: 33815612
PMC: 8014972.
DOI: 10.3892/etm.2021.9969.
Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function.
Larsen T, Jansen K
J Lipid Atheroscler. 2021; 10(1):8-23.
PMID: 33537250
PMC: 7838512.
DOI: 10.12997/jla.2021.10.1.8.
Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.
Hoevenaar M, Goossens D, Roorda J
J Renin Angiotensin Aldosterone Syst. 2020; 21(4):1470320320979097.
PMID: 33283602
PMC: 7724427.
DOI: 10.1177/1470320320979097.
Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review).
Petrakis D, Margina D, Tsarouhas K, Tekos F, Stan M, Nikitovic D
Mol Med Rep. 2020; 22(1):9-19.
PMID: 32377709
PMC: 7248467.
DOI: 10.3892/mmr.2020.11127.
Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division.
Vecchiola A, Fuentes C, Solar I, Lagos C, Opazo M, Munoz-Durango N
Front Endocrinol (Lausanne). 2020; 11:223.
PMID: 32373073
PMC: 7186315.
DOI: 10.3389/fendo.2020.00223.
Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome.
Jahandideh F, Wu J
Int J Mol Sci. 2020; 21(6).
PMID: 32235782
PMC: 7139547.
DOI: 10.3390/ijms21062192.